These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 9806669

  • 1. Increased anticoagulation during cardiopulmonary bypass by prostaglandin E1.
    Kozek-Langenecker SA, Wanzel O, Berger R, Kettner SC, Coraim F.
    Anesth Analg; 1998 Nov; 87(5):985-8. PubMed ID: 9806669
    [Abstract] [Full Text] [Related]

  • 2. Monitoring thrombin generation with prothrombin fragment 1.2 assay during cardiopulmonary bypass surgery.
    Knudsen L, Hasenkam JM, Kure HH, Hughes P, Bellaiche L, Ahlburg P, Djurhuus C.
    Thromb Res; 1996 Oct 01; 84(1):45-54. PubMed ID: 8885146
    [Abstract] [Full Text] [Related]

  • 3. Cell activation and thrombin generation in heparin bonded cardiopulmonary bypass circuits using a novel in vitro model.
    Bannan S, Danby A, Cowan D, Ashraf S, Gesinde M, Martin P.
    Eur J Cardiothorac Surg; 1997 Aug 01; 12(2):268-75. PubMed ID: 9288518
    [Abstract] [Full Text] [Related]

  • 4. Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques.
    Owings JT, Pollock ME, Gosselin RC, Ireland K, Jahr JS, Larkin EC.
    Arch Surg; 2000 Sep 01; 135(9):1042-7. PubMed ID: 10982508
    [Abstract] [Full Text] [Related]

  • 5. Thrombin generation during cardiopulmonary bypass using heparin-coated or standard circuits.
    Ernofsson M, Thelin S, Siegbahn A.
    Scand J Thorac Cardiovasc Surg; 1995 Sep 01; 29(4):157-65. PubMed ID: 8789468
    [Abstract] [Full Text] [Related]

  • 6. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
    Ovrum E, Brosstad F, Am Holen E, Tangen G, Abdelnoor M, Oystese R.
    Eur J Cardiothorac Surg; 1996 Sep 01; 10(6):449-55. PubMed ID: 8817142
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anticoagulation for cardiac surgery in patients receiving preoperative heparin: use of the high-dose thrombin time.
    Shore-Lesserson L, Manspeizer HE, Bolastig M, Harrington D, Vela-Cantos F, DePerio M.
    Anesth Analg; 2000 Apr 01; 90(4):813-8. PubMed ID: 10735781
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?
    Dietrich W.
    J Cardiovasc Pharmacol; 1996 Apr 01; 27 Suppl 1():S50-7. PubMed ID: 8938284
    [Abstract] [Full Text] [Related]

  • 14. Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response.
    Koster A, Huebler S, Merkle F, Hentschel T, Gründel M, Krabatsch T, Tambeur L, Praus M, Habazettl H, Kuebler WM, Kuppe H.
    Anesth Analg; 2004 Feb 01; 98(2):285-290. PubMed ID: 14742356
    [Abstract] [Full Text] [Related]

  • 15. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ, Joist JH.
    J Cardiothorac Vasc Anesth; 1999 Aug 01; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [Abstract] [Full Text] [Related]

  • 16. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?
    Brinks HJ, Weerwind PW, Bogdan S, Verbruggen H, Brouwer MH.
    Perfusion; 2001 Jan 01; 16(1):3-12. PubMed ID: 11192305
    [Abstract] [Full Text] [Related]

  • 17. Correcting thrombin generation ex vivo using different haemostatic agents following cardiac surgery requiring the use of cardiopulmonary bypass.
    Percy CL, Hartmann R, Jones RM, Balachandran S, Mehta D, Dockal M, Scheiflinger F, O'Donnell VB, Hall JE, Collins PW.
    Blood Coagul Fibrinolysis; 2015 Jun 01; 26(4):357-67. PubMed ID: 25928274
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.